COVID specific IgA monoclonal antibodies may provide effective immunity against coronavirus
A new study by researchers at MassBiologics of UMass Medical School published in Nature Communications suggests that COVID specific IgA monoclonal antibodies may provide effective immunity in the respiratory system against the novel coronavirus - a potentially critical feature of an effective vaccine.
.png)
No hay comentarios:
Publicar un comentario